TIDMCTEC

RNS Number : 9695X

ConvaTec Group PLC

07 May 2021

ConvaTec Group Plc

Results of Annual General Meeting

Reading, United Kingdom 7 May 2021 - Poll Result

ConvaTec Group Plc ("ConvaTec") held its annual general meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below:

 
                                        For                   Against          Total Votes       % of        Number 
                                    (see note 2)            (see note 2)           cast        ISC Voted    of Votes 
                                                                                                            Withheld 
                                                                                                            (see note 
                                                                                                               3) 
 Resolution                    No of shares    %        No of shares   % 
                              --------------  -------  -------------  ----- 
      Receive Annual 
       Report and 
 1     Accounts                1,744,608,352    99.96        777,616   0.04   1,745,385,968       87.08%    1,480,001 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Approve the 
       Directors' 
       Remuneration 
 2     Report                  1,698,130,077    97.23     48,413,492   2.77   1,746,543,569       87.14%      322,400 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Declare Final 
 3     Dividend                1,740,839,314    99.66      5,915,934   0.34   1,746,755,248       87.15%      110,721 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect John 
       McAdam as a 
 4     director                1,726,805,777    98.88     19,520,971   1.12   1,746,326,748       87.13%      539,221 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Karim 
       Bitar as a 
 5     director                1,745,847,330    99.95        907,151   0.05   1,746,754,481       87.15%      111,488 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Frank 
       Schulkes as 
 6     a director              1,739,573,569    99.59      7,176,168   0.41   1,746,749,737       87.15%      116,232 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Margaret 
       Ewing as a 
 7     director                1,735,171,507    99.34     11,573,127   0.66   1,746,744,634       87.15%      121,335 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Brian 
 8     May as a director       1,726,852,048    98.86     19,898,392   1.14   1,746,750,440       87.15%      115,529 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Rick 
       Anderson as 
 9     a director              1,732,922,453    99.21     13,822,181   0.79   1,746,744,634       87.15%      121,335 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Regina 
       Benjamin as 
 10    a director              1,733,824,898    99.26     12,925,036   0.74   1,746,749,934       87.15%      116,035 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-elect Sten 
       Scheibye as 
 11    a director              1,745,567,146    99.93      1,187,335   0.07   1,746,754,481       87.15%      111,488 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Elect Heather 
       Mason as a 
 12    director                1,744,886,278    99.89      1,863,459   0.11   1,746,749,737       87.15%      116,232 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Elect Constantin 
       Coussios as 
 13    a director              1,744,393,943    99.87      2,356,497   0.13   1,746,750,440       87.15%      115,529 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Re-appoint 
       Deloitte LLP 
 14    as auditor              1,746,633,262    99.99        118,345   0.01   1,746,751,607       87.15%      114,362 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Authorise the 
       directors to 
       determine the 
       remuneration 
       of the Company's 
 15    auditor                 1,746,753,488   100.00            433   0.00   1,746,753,921       87.15%      112,048 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Authorise political 
       donations and 
 16    political expenditure   1,721,717,493    98.58     24,812,022   1.42   1,746,529,515       87.14%      336,454 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Authorise allotment 
 17    of shares               1,623,589,106    92.97    122,709,426   7.03   1,746,298,532       87.13%      567,437 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Disapply pre-emption 
 18    rights*                 1,736,680,253    99.45      9,522,182   0.55   1,746,202,435       87.12%      663,534 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Disapply pre-emption 
       rights in connection 
       with an acquisition 
       or specified 
 19    capital investment*     1,691,979,685    96.87     54,580,936   3.13   1,746,560,621       87.14%      305,348 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Authorise purchase 
 20    of own shares*          1,741,411,621    99.75      4,350,959   0.25   1,745,762,580       87.10%    1,103,389 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
      Call general 
       meetings on 
 21    14 days' notice*        1,657,330,730    94.88     89,418,003   5.12   1,746,748,733       87.15%      117,236 
     -----------------------  --------------  -------  -------------  -----  --------------  -----------  ----------- 
 

*Special Resolution

NOTES:

   1.   All resolutions were passed. 
   2.   Votes "For" and "Against" are expressed as a percentage of votes received. 

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at close of business on 5 May 2021 was 2,004,347,138 shares; 87.15% of voting capital was instructed.

   5.   Computershare acted as scrutineer of the poll on all resolutions. 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

Enquiries

Analysts and Investors

   Kate Postans, Vice President Investor Relations, ConvaTec    +44 (0)7826 447 807 

ir@convatec.com

Media

   Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGUBSORAOUVRAR

(END) Dow Jones Newswires

May 07, 2021 09:50 ET (13:50 GMT)

Convatec (LSE:CTEC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Convatec Charts.
Convatec (LSE:CTEC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Convatec Charts.